Correlation of RET somatic mutations with clinicopathological features in sporadic medullary thyroid carcinomas

被引：0

作者：

M M Moura

B M Cavaco

A E Pinto

R Domingues

J R Santos

M O Cid

M J Bugalho

V Leite

机构：

[1] Centro de Investigação de Patobiologia Molecular (CIPM),

[2] Instituto Português de Oncologia de Lisboa Francisco Gentil E.P.E.,undefined

[3] Rua Prof. Lima Basto,undefined

[4] Serviço de Anatomia Patológica,undefined

[5] Instituto Português de Oncologia de Lisboa Francisco Gentil E.P.E.,undefined

[6] Rua Prof. Lima Basto,undefined

[7] Serviço de Cirurgia Cabeça e Pescoço,undefined

[8] Instituto Português de Oncologia de Lisboa Francisco Gentil E.P.E.,undefined

[9] Rua Prof. Lima Basto,undefined

[10] Serviço de Endocrinologia,undefined

[11] Instituto Português de Oncologia de Lisboa Francisco Gentil E.P.E.,undefined

[12] Rua Prof. Lima Basto,undefined

[13] Faculdade de Ciências Médicas,undefined

[14] Universidade Nova de Lisboa,undefined

[15] Campo Mártires da Pátria 130,undefined

来源：

British Journal of Cancer | 2009年 / 100卷

关键词：

sporadic medullary thyroid carcinoma; proto-oncogene; somatic mutation; genetic screening; prognosis;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Screening of REarranged during Transfection (RET) gene mutations has been carried out in different series of sporadic medullary thyroid carcinomas (MTC). RET-positive tumours seem to be associated to a worse clinical outcome. However, the correlation between the type of RET mutation and the patients' clinicopathological data has not been evaluated yet.

引用

页码：1777 / 1783

页数：6

共 50 条

[21] Somatic RET Indels in Sporadic Medullary Thyroid Cancer: Prevalence and Response to Selpercatinib
Elisei, Rossella
Ciampi, Raffaele
Matrone, Antonio
Prete, Alessandro
Gambale, Carla
Ramone, Teresa
Simeakis, George
Materazzi, Gabriele
Torregrossa, Liborio
Ugolini, Clara
Romei, Cristina
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (08): : 2195 - 2202
[22] Does a somatic deletion in RET clarify the sporadic nature of medullary thyroid carcinoma?
O. Gimm
D. J. Marsh
Journal of Endocrinological Investigation, 2003, 26 : 381 - 383
[23] RET gene mutations and polymorphisms in medullary thyroid carcinomas in Indian patients
B P Sharma
D Saranath
Journal of Biosciences, 2011, 36 : 603 - 611
[24] RET gene mutations and polymorphisms in medullary thyroid carcinomas in Indian patients
Sharma, B. P.
Saranath, D.
JOURNAL OF BIOSCIENCES, 2011, 36 (04) : 603 - 611
[25] MUTATIONS OF CODON-918 IN THE RET PROTOONCOGENE CORRELATE TO POOR-PROGNOSIS IN SPORADIC MEDULLARY-THYROID CARCINOMAS
ZEDENIUS, J
LARSSON, C
BERGHOLM, U
BOVEE, J
SVENSSON, A
HALLENGREN, B
GRIMELIUS, L
BACKDAHL, M
WEBER, G
WALLIN, G
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (10): : 3088 - 3090
[26] Relevance of RET proto-oncogene mutations in sporadic medullary thyroid carcinoma
Wohllk, N
Cote, GJ
Bugalho, MMJ
Ordonez, N
Evans, DB
Goepfert, H
Khorana, S
Schultz, P
Richards, CS
Gagel, RF
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (10): : 3740 - 3745
[27] RET mutations and medullary thyroid cancer
Lin, Chia-Chi
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2011, 110 (11) : 731 - 731
[28] Identification of a novel somatic mutation in the RET proto oncogene in a patient with sporadic medullary thyroid carcinoma
MatiasGuiu, X
Lagarda, E
Calaf, M
Azpiroz, A
DeLeiva, A
Prat, J
Baiget, M
HUMAN MUTATION, 1997, 9 (05) : 476 - 476
[29] No correlation between RET immunostaining and the codon 918 mutation in sporadic medullary thyroid carcinoma
Bockhorn, M
Frilling, A
Kalinin, V
Schröder, S
Broelsch, CE
LANGENBECKS ARCHIVES OF SURGERY, 1999, 384 (01) : 60 - 64
[30] Ret proto-oncogene mutations and polymorphisms in French medullary thyroid carcinomas patients
Gorisse, M. C.
Pochart, J. -M.
Schvartz, C.
Gaillard, D.
Larbre, H.
Delvincourt, C.
HORMONE RESEARCH, 2007, 68 : 22 - 23

← 1 2 3 4 5 →